| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/29/2010 | EP1727817B1 Azabicyclooctan-3-one derivatives and use thereof |
| 09/29/2010 | EP1689736B1 Biocidal siloxane coating material containing n-halogenated amine and amide functional groups |
| 09/29/2010 | EP1675824B1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists |
| 09/29/2010 | EP1638548B1 Preventing atrial fibrillation (af) with the use of statin drugs |
| 09/29/2010 | EP1628957B1 Sulfopyrroles |
| 09/29/2010 | EP1615889B1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/29/2010 | EP1615698B1 New amide derivatives and pharmaceutical use thereof |
| 09/29/2010 | EP1578412B1 Pharmaceutical compositions and method of treating parkinson's disease |
| 09/29/2010 | EP1575670B1 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 09/29/2010 | EP1575569B1 Oral drug delivery system comprising high viscosity liquid carrier materials |
| 09/29/2010 | EP1572952B1 Novel polynucleotide and polypeptide sequences and uses thereof |
| 09/29/2010 | EP1534695B1 Tyrosine kinase inhibitors |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/29/2010 | EP1421074B1 Novel compounds |
| 09/29/2010 | EP1413294B1 Composition comprising sustained-release fine particles for quick-disintegrating tablets in the buccal cavity |
| 09/29/2010 | EP1399411B1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies |
| 09/29/2010 | EP1313731B1 Thiazolidine derivatives and its use as antifungal agent |
| 09/29/2010 | EP1086950B1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |
| 09/29/2010 | CN201591849U Tizanidine hydrochloride scratch tablet |
| 09/29/2010 | CN1984640B Topical antiviral formulations |
| 09/29/2010 | CN1972938B 环状胺化合物 Cyclic amine compound |
| 09/29/2010 | CN1953978B 5-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b] indol-2-ones and analogs as anti-virals |
| 09/29/2010 | CN1949977B Anti-coronavirus compounds |
| 09/29/2010 | CN1935254B Method for neuregulin treating cardio vascular disease, and composition |
| 09/29/2010 | CN1934077B 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| 09/29/2010 | CN1923209B Phthiobuzonum eye drops containing sodium hyaluronate and its preparing process |
| 09/29/2010 | CN1919246B Traditional Chinese medicine for treating cardiovascular diseases |
| 09/29/2010 | CN1919239B Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 09/29/2010 | CN1919236B Medicine for treating cardiovascular and cerebrovascular diseases |
| 09/29/2010 | CN1899287B Slow release medicinal composition for treating anxiety and its preparing method |
| 09/29/2010 | CN1893919B Endoparasiticidal agents for topical application |
| 09/29/2010 | CN1882569B 喹唑啉衍生物 Quinazoline derivatives |
| 09/29/2010 | CN1872250B Composition of medication for treating headache |
| 09/29/2010 | CN1872064B Drop pills of piperazine ferulic acid, and preparation method |
| 09/29/2010 | CN1872052B Drop pills of simvastatin, and preparation method |
| 09/29/2010 | CN1872040B Drop pills of sodium ferulic acid, and preparation method |
| 09/29/2010 | CN1872037B Drop pills of paeonol, and preparation method |
| 09/29/2010 | CN1852881B Benzotropolone derivatives and modulation of inflammatory response |
| 09/29/2010 | CN1832734B Substituted 2-amino-1,2,3,4-tetrahydronaphthalene of depression |
| 09/29/2010 | CN1827634B Nitrate derivatives of glycyrrhetic acid and glycyrrhetinic acid and pharmaceutical use thereof |
| 09/29/2010 | CN1823827B Medicine and food dual purpose nutritive product for preventing and treating xeroma and its manufacturing method |
| 09/29/2010 | CN1816549B Inhibitors of phosphatidylinositol 3-kinase |
| 09/29/2010 | CN1810777B Compound for preventing and treating bacterial infection and its preparation and use |
| 09/29/2010 | CN1794987B Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 09/29/2010 | CN1794974B 药物递送体系 Drug delivery system |
| 09/29/2010 | CN1778337B Preparation of compound Danshen Root tablet |
| 09/29/2010 | CN1753673B Prodrugs of GABA analogs, compositions and uses thereof |
| 09/29/2010 | CN1695740B Composite body of fiber protein adhesive and antibiotics in use for treating infection in deep part, and application |
| 09/29/2010 | CN1679573B Implantable vascular device for delivery of topotecan in combination with rapamycin |
| 09/29/2010 | CN1674868B Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
| 09/29/2010 | CN1660064B Nage lieqin self-emulsifying system for releasing medicine |
| 09/29/2010 | CN1475207B Solid oral dosage mode containing walshaden and hydrochloric thizaine |
| 09/29/2010 | CN101849007A RNA antagonist compounds for the modulation of HER3 |
| 09/29/2010 | CN101848922A Novel mangiferin calcium salts, the method for its preparation and its use |
| 09/29/2010 | CN101848918A Mitochondrial compositions and uses thereof |
| 09/29/2010 | CN101848910A 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 09/29/2010 | CN101848909A Pyrrolo(3,2-C) pyridines useful as inhibitors of protein kinases |
| 09/29/2010 | CN101848907A Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition |
| 09/29/2010 | CN101848903A Piperazine derivative having affinity for the histamine H3 receptor |
| 09/29/2010 | CN101848901A Thiazolidinedione analogues for the treatment of hypertension |
| 09/29/2010 | CN101848900A Crystalline hydrate of betamimetika and use as medicament thereof |
| 09/29/2010 | CN101848898A Phthalazinone derivatives as inhibitors of PARP-1 |
| 09/29/2010 | CN101848896A Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 09/29/2010 | CN101848895A Combination of anti-angiogenic substance and anti-tumor platinum complex |
| 09/29/2010 | CN101848894A New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution |
| 09/29/2010 | CN101848893A 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 09/29/2010 | CN101848892A Hydrobenzamide derivatives as inhibitors of HSP90 |
| 09/29/2010 | CN101848726A Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury |
| 09/29/2010 | CN101848724A Use of TRL-2 antagonists for treatment of reperfusion injury and tissue damage |
| 09/29/2010 | CN101848717A Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 09/29/2010 | CN101848716A Use of a gestagen in combination with an estrogen and one or more pharmaceutically tolerable excipients/carriers for lactose-free oral contraceptive |
| 09/29/2010 | CN101848715A Two-component eye drops containing pirenoxine |
| 09/29/2010 | CN101848714A Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient |
| 09/29/2010 | CN101848713A Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
| 09/29/2010 | CN101848712A Treatment of progressive neurodegenerative disease with ibudilast |
| 09/29/2010 | CN101848710A Anthelmintic combination |
| 09/29/2010 | CN101848709A Treatment of oral pharyngeal dysphagia |
| 09/29/2010 | CN101848708A Corticosteroids to treat epothilone or epothilone derivative induced diarrhea |
| 09/29/2010 | CN101848706A Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol |
| 09/29/2010 | CN101848705A Process for preparing clopidogrel compositions |
| 09/29/2010 | CN101848701A Water-immiscible materials as vehicles for drug delivery |
| 09/29/2010 | CN101848700A Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor |
| 09/29/2010 | CN101848699A Stabilized pediatric suspension of carisbamate |
| 09/29/2010 | CN101845075A 6-substituted-4-azepine-A-homo-3-oxosteroid compound and application thereof to preparing anti-tumor medicine |
| 09/29/2010 | CN101845069A Derivative of 4'-substituted 6,11-2-oxygen-carithromycin A |
| 09/29/2010 | CN101845060A Beta-carboline ruthenium compound as well as preparation method and application thereof |
| 09/29/2010 | CN101845057A Substituted phenol for methylal phosphate anesthetic and sedative drugs and preparation method thereof |
| 09/29/2010 | CN101845051A Nitrogen-containing heterocyclic thienopyridine compounds and preparation method and application thereof |
| 09/29/2010 | CN101845044A New crystal forms of Abafungin and preparation method thereof |
| 09/29/2010 | CN101845034A Preparation and application method of scutellarin |
| 09/29/2010 | CN101845033A Paramagnetic iron and selenium quercetin complex and preparation method as well as application thereof |
| 09/29/2010 | CN101845032A Phenolic compound and uses |
| 09/29/2010 | CN101845026A 5-(4-chlorophenylmethyl)-4-tertiary butyl thiazole derivatives and preparation method and application thereof |
| 09/29/2010 | CN101845023A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 09/29/2010 | CN101845021A Quinazoline ketones alkaloid and preparation method and application thereof |
| 09/29/2010 | CN101845018A Non-catechol aporphine compound as well as pharmaceutic composition and application thereof |
| 09/29/2010 | CN101845009A Structural carotenoid analogs for the inhibition and amelioration of disease |
| 09/29/2010 | CN101844970A Dibenzocyclooctene lignan derivatives with bioactivity |
| 09/29/2010 | CN101844811A Niobium tungstate compound for resisting hepatitis virus |